KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.79M	-
CFO	Gall Matthew	235.0K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 11, 2022	Hagen Brett R84	Chief Accounting Officer	Sell	24,000	$8.13	$195,182.51	-12.4%	-29.1%	-83.3%
Nov 10, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	13,408	$8.00	$107,292.84	-1.7%	-24.6%	-82.3%
Oct 24, 2022	Hagen Brett R84	Chief Accounting Officer	Sell	13,679	$8.43	$115,297.94	-4.2%	-30.4%	-80.7%
Oct 20, 2022	Atillasoy Ercem78	See Remarks	Sell	2,095	$8.72	$18,272.40	-0.8%	-38.3%	-82.4%
Oct 19, 2022	Hallal David79	Director, 10% Owner	Sell	600,000	$8.45	$5,070,000.00	-81.3%	-40.8%	-83.6%
Oct 19, 2022	Sinha Vikas84	See Remarks	Sell	1,449	$9.36	$13,563.65	-0.1%	-40.8%	-83.6%
Oct 19, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	1,070	$9.36	$10,015.95	-0.3%	-40.8%	-83.6%
Oct 19, 2022	Miller Edward82	General Counsel	Sell	553	$9.36	$5,176.47	-0.2%	-40.8%	-83.6%
Sep 29, 2022	Hallal David79	Director, 10% Owner	Sell	400,000	$7.35	$2,940,920.00	-35.7%	-40.1%	-72.6%
Sep 2, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	493	$7.89	$3,889.18	-0.1%	-0.9%	-57.9%

← PrevPage 12Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC